Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Six Pharma Cos Get Notice for Overpricing (India)

This article was originally published in PharmAsia News

Executive Summary

India's National Pharmaceutical Pricing Authority (NPAA) has begun taking action against drug companies accused of producing overpriced or unapproved medications. Previously 11 pharmaceutical companies had volunteered to cut prices on 886 drugs. NPAA investigations found that six companies were not complying with the reduction on 58 different medications. They also discovered that 39 unapproved versions the 886 drugs had been made available. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts